Cambridge Investment Research Advisors, Inc. - CLEVELAND BIOLABS INC ownership

CLEVELAND BIOLABS INC's ticker is CBLI and the CUSIP is 185860103. A total of 36 filers reported holding CLEVELAND BIOLABS INC in Q1 2014. The put-call ratio across all filers is 0.10 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cambridge Investment Research Advisors, Inc. ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q4 2014$6,000
-14.3%
22,500
+50.0%
0.00%
Q3 2014$7,0000.0%15,0000.0%0.00%
Q2 2014$7,000
-30.0%
15,0000.0%0.00%
Q1 2014$10,000
-44.4%
15,0000.0%0.00%
-100.0%
Q4 2013$18,000
-25.0%
15,000
-0.7%
0.00%0.0%
Q3 2013$24,0000.0%15,1000.0%0.00%0.0%
Q2 2013$24,00015,1000.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q1 2014
NameSharesValueWeighting ↓
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 640,700$1,006,0000.21%
GOODNOW INVESTMENT GROUP, LLC 598,461$940,0000.15%
BHR Capital LLC 300,000$468,0000.04%
LADENBURG THALMANN FINANCIAL SERVICES INC. 752,038$1,292,0000.04%
Van Cleef Asset Management,Inc 20,000$31,0000.02%
RICE HALL JAMES & ASSOCIATES, LLC 61,535$97,0000.01%
KINGS POINT CAPITAL MANAGEMENT 10,000$16,0000.01%
TAURUS ASSET MANAGEMENT, LLC 15,000$24,0000.01%
WealthTrust Fairport, LLC 19,650$31,0000.01%
OPPENHEIMER & CO INC 47,133$74,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders